Antineoplastics: Reversible posterior leukoencephalopathy syndrome (first report with pegaspargase) in paediatric patients: 4 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1356, 2011-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ciclosporin/tacrolimus: Reversible posterior leukoencephalopathy syndrome in paediatric patients: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Antineoplastics/immunosuppressants: Reversible posterior leukoencephalopathy syndrome: 6 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1265, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antineoplastics: Atypical reversible posterior leukoencephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1427, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Antineoplastics/filgrastim: Reversible posterior leukoencephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1151, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Antineoplastics/monoclonal antibodies: Posterior reversible encephalopathy in paediatric patients: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1227, 2008-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite